Top News

Mar 29, 2017
The mAb is the first approved treatment that targets the progressive form of the disease.
Mar 16, 2017
By Pharmaceutical Technology Editors
Human antibody for Zika virus could help in the treatment and prevention of the infection.
Mar 13, 2017
Trump’s choice for FDA commissioner faces drug pricing, regulatory, and approval challenges.
Mar 10, 2017
The White House said President Trump will nominate Scott Gottlieb to the position of FDA commissioner.
Mar 02, 2017
The Mutual Recognition Agreement will allow FDA and EU inspectors to recognize each other’s work and avoid the duplication of drug inspections.
Feb 16, 2017
The Patent Trial and Appeal Board ruled in favor of the Broad Institute, allowing the institution to keep patents for its CRISPR-Cas9 gene-editing technology.
Feb 16, 2017
PhRMA submits comments to the The Office of the United States Trade Representative encouraging protection of US innovation in foreign markets.
Feb 10, 2017
A total of 166 biotech executives penned an open letter expressing concern over President Donald Trump’s executive order on immigration.
Feb 07, 2017
Aggressive petitioning by ViroPharma kept a generic equivalent to Vancocin off the market for more than two years.
Feb 01, 2017
A change in the tax code could help the company create more jobs in the United States, while fewer FDA regulations could help reduce drug prices, according to Pfizer CEO Ian Read.
lorem ipsum